Tag:
IMO-3100
Latest Headlines
Latest Headlines
UPDATED: Idera gets FDA green light for Phase II psoriasis drug test
Idera Pharmaceuticals ( $IDRA ) is ending the week with a second piece of positive news. The Cambridge, MA-based drug developer disclosed Dec. 1 that the FDA has reversed a clinical hold on IMO-3100,
